Bill > H1983

This bill expands the scope of practice for optometrists by allowing them to utilize and prescribe a wider range of therapeutic pharmaceutical agents, including those used to treat anaphylaxis (a severe allergic reaction), and to treat ocular diseases and abnormalities. It amends existing laws, specifically Chapter 94C and Chapter 112 of the General Laws, to reflect these changes. Key provisions include authorizing optometrists to use epinephrine or adrenaline for anaphylaxis treatment, permitting them to prescribe topical and oral medications for eye conditions like glaucoma, and establishing a new certification process (Section 68C) for optometrists to demonstrate competency in using and prescribing these agents. The bill also clarifies that optometrists cannot treat systemic diseases, perform invasive surgery, or administer certain types of injections, except for the specified anaphylaxis treatment. Furthermore, it mandates that optometrists refer patients to physicians when conditions requiring treatment beyond optometric scope are identified, and requires optometrists to participate in patient safety reporting through the Betsy Lehman Center. Finally, it directs the Department of Public Health and the Board of Registration in Optometry to create necessary rules and regulations within 90 days of the bill's enactment.